0000000000186003

AUTHOR

Namdar Manouchehri

showing 2 related works from this author

28 Milrinone is Preferred to Levosimendan for Mesenteric Perfusion in Hypoxia-Reoxygenated Newborn Piglets on Dopamine

2010

28 Milrinone is Preferred to Levosimendan for Mesenteric Perfusion in Hypoxia-Reoxygenated Newborn Piglets on Dopamine

medicine.medical_specialtyintegumentary systembusiness.industryanimal diseasesLevosimendanHypoxia (medical)bacterial infections and mycosesfluids and secretionsDopamineInternal medicineAnesthesiaPediatrics Perinatology and Child HealthCardiologyMedicineMilrinonemedicine.symptombusinessPerfusionmedicine.drugPediatric Research
researchProduct

Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine

2012

INTRODUCTION There is little information regarding the comparative hemodynamic effects of adding milrinone or levosimendan to dopamine infusion in hypoxia-reoxygenated (H-R) newborns. RESULTS Severely hypoxic piglets had cardiogenic shock with depressed cardiac index (CI) and mean arterial pressure (MAP). The hemodynamics deteriorated gradually after initial recovery upon reoxygenation. Heart rate and CI improved with milrinone (D+M) and levosimendan (D+L) administration (P < 0.05 vs. control). Both regimens improved carotid arterial flow and carotid vascular resistance; D+M additionally improved superior mesentric arterial flow (all P < 0.05 vs. control). No effect was found on renal arter…

Mean arterial pressureCardiotonic AgentsSwineDopamineVasodilator AgentsHemodynamicsMyocardial ReperfusionMyocardial Reperfusion Injury030204 cardiovascular system & hematologyArticle03 medical and health sciences0302 clinical medicine030225 pediatricsMedicineAnimalsHypoxiaSimendanbusiness.industryCardiogenic shockHemodynamicsHydrazonesLevosimendanHypoxia (medical)medicine.disease3. Good healthMesenteric ArteriesPyridazinesOxidative Stressmedicine.anatomical_structureAnimals NewbornAnesthesiaPediatrics Perinatology and Child HealthModels AnimalVascular resistanceMilrinoneDrug Therapy Combinationmedicine.symptombusinessPerfusionmedicine.drugMilrinonePediatric research
researchProduct